EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Human Umbilical Cord-Derived Mesenchymal Stem Cells-Involved Strategies: Advancing Tendon Injuries Therapy Towards Clinical Translation

Mumin Cao, Mengze Tong, Yunmeng Pu, Xuepeng Lv, Yimin Sun, Haoyu Zhang, Renwang Sheng, Hao Wang, Yucheng Gao, Guangchun Dai, Fei Xiong, Qianqian Wang und 1 weitere

Stem Cell Reviews and Reports · 2026

DOI: 10.1007/s12015-025-11054-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cell Reviews and Reports, 2026. Verfasst von Mumin Cao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, No. 87 Ding Jia Qiao, Nanjing, Jiangsu, 210009, PR China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Tendon Injuries, Umbilical Cord, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 128 Literaturangaben. Gefördert von: SEU Innovation Capability Enhancement Plan for Doctoral Students, Natural Science Foundation of Jiangsu Province for Young Scholars, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effective repair of tendon injuries represents a significant challenge in the selection of an appropriate regeneration strategy. Meanwhile, umbilical cord-derived mesenchymal stem cells (UC-MSCs) have been employed in the treatment of a range of diseases due to a number of advantageous characteristics, including low immunogenicity, high proliferation and differentiation potential, extensive availability, ease of large-scale production, absence of ethical constraints, and immunomodulatory functions. It has demonstrated considerable clinical application potential and offer a promising avenue for the treatment of tendon injuries. The core strategies may be broadly classified into three categories: direct stem cell injection, transplantation of biological scaffolds with tissue engineering technology, and the use of stem cell-derived products. This review will provide an in-depth analysis of the pathophysiological mechanisms of tendon repair, describe the unique properties of UC-MSCs, and systematically evaluate the advantages and limitations of these treatment strategies, aiming to provide a solid theoretical basis and scientific guidance for the biological research and clinical application of UC-MSCs in the field of tendon repair. The translational potential of this article: Given the low immunogenicity, good biosafety, and strong differentiation potential possessed by UC-MSCs, it is expected to provide a both safe and effective therapeutic option for tendon injuries through certain processing measures, such as combining UC-MSCs with biomaterials or extracting their products. In addition, the extraction process of UC-MSCs is simple and non-invasive, which makes it easy to realize clinical mass production. Therefore, the use of UC-MSCs for tendon repair is significant for clinical translation of tendon injury treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsTendon InjuriesUmbilical CordMesenchymal Stem Cell TransplantationTranslational Research, BiomedicalHumansCell DifferentiationTissue EngineeringAnimals

Stichwörter der Autor:innen

Cell-based therapiesHuman umbilical cordMesenchymal stem cellsRegenerative medicineTendon injury

Autor:innen und Institutionen

  • Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, No. 87 Ding Jia Qiao, Nanjing, Jiangsu, 210009, PR China.
  • School of Medicine, Southeast University, Nanjing, Jiangsu, PR China.
  • Orthopaedic Trauma Institute (OTI), Southeast University, Nanjing, Jiangsu, PR China.
  • Trauma Center, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, PR China.
  • State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences & Medical Engineering, Southeast University, Nanjing, Jiangsu, PR China.
  • Jiangsu Key Laboratory for Design and Manufacture of Micro-Nano Biomedical Instruments, School of Mechanical Engineering, Southeast University, Nanjing, PR China.

Förderung

  • SEU Innovation Capability Enhancement Plan for Doctoral Students
  • Natural Science Foundation of Jiangsu Province for Young Scholars
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Winfast Charity Foundation Project

Zitieren

APA

Cao, M., Tong, M., Pu, Y., Lv, X., Sun, Y., Zhang, H., Sheng, R., Wang, H., Gao, Y., Dai, G., Xiong, F., Wang, Q., & Rui, Y. (2026). Human Umbilical Cord-Derived Mesenchymal Stem Cells-Involved Strategies: Advancing Tendon Injuries Therapy Towards Clinical Translation. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-025-11054-9

Vancouver

Cao M, Tong M, Pu Y, Lv X, Sun Y, Zhang H, et al. Human Umbilical Cord-Derived Mesenchymal Stem Cells-Involved Strategies: Advancing Tendon Injuries Therapy Towards Clinical Translation. Stem Cell Reviews and Reports. 2026. doi:10.1007/s12015-025-11054-9

BibTeX
@article{Cao2026,
  author = {Cao, Mumin and Tong, Mengze and Pu, Yunmeng and Lv, Xuepeng and Sun, Yimin and Zhang, Haoyu and Sheng, Renwang and Wang, Hao and Gao, Yucheng and Dai, Guangchun and Xiong, Fei and Wang, Qianqian and Rui, Yunfeng},
  title = {Human Umbilical Cord-Derived Mesenchymal Stem Cells-Involved Strategies: Advancing Tendon Injuries Therapy Towards Clinical Translation},
  journal = {Stem Cell Reviews and Reports},
  year = {2026},
  doi = {10.1007/s12015-025-11054-9}
}
Kostenlos starten →